CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Clinical trial NCT00710892 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00710892
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma Myelodysplastic Syndrome Chronic Myeloid Leukemia

Start date: 2008-12-01
Primary completion: 2011-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.